These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1586 related articles for article (PubMed ID: 17460447)

  • 41. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases.
    Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM
    Mod Pathol; 2006 Jan; 19(1):97-105. PubMed ID: 16294196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
    Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung.
    Wang CW; Wu TI; Yu CT; Wu YC; Teng YH; Chin SY; Lai CH; Chen TC
    Am J Clin Pathol; 2009 May; 131(5):715-22. PubMed ID: 19369633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of HPV analysis for evaluation of possible metastatic disease in women with cervical cancer.
    Plaza JA; Ramirez NC; Nuovo GJ
    Int J Gynecol Pathol; 2004 Jan; 23(1):7-12. PubMed ID: 14668543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms.
    Hart WR
    Pathol Int; 2005 May; 55(5):231-43. PubMed ID: 15871720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
    Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women.
    Giordano G; D'Adda T; Gnetti L; Froio E; Merisio C; Melpignano M
    J Obstet Gynaecol Res; 2008 Apr; 34(2):210-7. PubMed ID: 18412784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach.
    Park TW; Zivanovic O; Theuerkauf I; Dürkop B; Hernando JJ; Simon M; Büttner R; Kuhn W
    Int J Oncol; 2004 Apr; 24(4):829-36. PubMed ID: 15010819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
    Gaggero G; Sola S; Mora M; Fulcheri E
    Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix with ovarian metastasis of the former component: a report of 2 cases.
    Ramalingam P; Malpica A; Deavers MT
    Int J Gynecol Pathol; 2012 Sep; 31(5):490-6. PubMed ID: 22833092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality.
    Khunamornpong S; Suprasert P; Pojchamarnwiputh S; Na Chiangmai W; Settakorn J; Siriaunkgul S
    Gynecol Oncol; 2006 Apr; 101(1):152-7. PubMed ID: 16300822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.